Anhui Wanyi Science and Technology Co Ltd

Wanyi Technology released its 2026 interim report, with net profit attributable to the parent company reaching 31.03 million yuan, a year-on-year surge of 2863.13%. Total operating revenue was 390 million yuan, up 26.78% year-on-year, marking two consecutive years of growth. Net cash outflow from operating activities was 3.68 million yuan, down 116.64% from the same period last year. The company's latest asset-liability ratio is 42.45%, gross margin is 50.46%, ROE is 3.89%, and diluted earnings per share is 0.25 yuan.

Construction Machinery (600984) plans to acquire 100% equity in Pucheng Clean Energy Chemical Co., Ltd. through a combination of share issuance and cash payment, along with raising supporting funds, constituting a major asset restructuring. Trading in the company's A-shares will be suspended from August 11, 2026, for an expected period of no more than 10 trading days. Jiangbolong disclosed its semi-annual report, with operating revenue reaching 24.088 billion yuan in the first half of 2026, up 136.26% year-on-year, and net profit attributable to shareholders of the listed company at 10.577 billion yuan, up 71,528.66% year-on-year. Gan & Lee Pharmaceuticals signed a licensing agreement with Menarini for the bofanglutide project. Menarini will pay a non-refundable upfront payment of 62 million euros, with milestone payments totaling up to 664 million euros, plus a sales royalty at a maximum double-digit percentage rate. In addition, several companies disclosed semi-annual results: Fangyuan turned a profit year-on-year, Wanyi Technology's net profit rose 2,863.13% year-on-year, and Hengyi Petrochemical's net profit rose 2,500.73% year-on-year, with a planned dividend of 9 yuan per 10 shares. Jiangbolong, Zhaochi, and Beijing Junzheng, among others, announced share buyback plans. Kunlun Wanwei plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange.